Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SMN1 antibody

This anti-SMN1 antibody is a Mouse Monoclonal antibody detecting SMN1 in WB and IP. Suitable for Human.
Catalog No. ABIN6253498

Quick Overview for SMN1 antibody (ABIN6253498)

Target

See all SMN1 Antibodies
SMN1 (Survival of Motor Neuron 1, Telomeric (SMN1))

Reactivity

  • 56
  • 31
  • 14
  • 6
  • 6
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 62
  • 9
Mouse

Clonality

  • 53
  • 18
Monoclonal

Conjugate

  • 33
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SMN1 antibody is un-conjugated

Application

  • 52
  • 24
  • 13
  • 13
  • 12
  • 10
  • 8
  • 8
  • 7
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB), Immunoprecipitation (IP)

Clone

7B10
  • Purpose

    anti-Survival Motor Neuron Protein (human), mAb (7B10)

    Characteristics

    Monoclonal Antibody. Recognizes a sequence of up to 9 amino acids in the N-terminal domain of human SMN. Isotype: Mouse IgG1. Clone: 7B10. Applications: IP, WB. Liquid. In PBS. The SMN complex plays an essential role in spliceosomal snRNP assembly in the cytoplasm and is required for pre-mRNA splicing in the nucleus. It may also play a role in the metabolism of snoRNPs. It is expressed in a wide variety of tissues, including high levels in brain, kidney and liver, moderate levels in skeletal and cardiac muscle and low levels in fibroblasts and lymphocytes. Mutations in SMN cause spinal muscular atrophy 1 (SMA1). Spinal muscular atrophy is a group of neuromuscular disorders characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. The antibody was used extensively to purify and characterize the macromolecular SMN complex from cultured human cells. The antibody binds with high affinity and specificity to its epitope, which comprises a sequence of up to 9 amino acids in the N-terminal part of human SMN. It allows the native elution of bound antigen with an excess of the cognate peptide. Via addition of the 7B10 epitope (TagIt epitope) to other proteins this purification strategy can also be exploited for purification of these fusion proteins and RNA-protein complexes from cells lacking this epitope on endogenous proteins, such as cells derived from C. elegans and Drosophila.

    Purification

    Protein A/G purified.

    Immunogen

    Recombinant human full-length survival motor neuron protein (SMN).

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Liquid. In PBS.

    Handling Advice

    Avoid freeze/thaw cycles.

    Storage

    4 °C,-20 °C

    Storage Comment

    Short Term Storage: +4°C

    Long Term Storage: -20°C

    Use & Stability: Stable for at least 1 year after receipt when stored at -20°C.

  • Target

    SMN1 (Survival of Motor Neuron 1, Telomeric (SMN1))

    Alternative Name

    Survival Motor Neuron Protein

    Background

    Alternate Names/Synonyms: SMN, Gemin-1, Component of Gems 1, BCD541

    Product Description: The SMN complex plays an essential role in spliceosomal snRNP assembly in the cytoplasm and is required for pre-mRNA splicing in the nucleus. It may also play a role in the metabolism of snoRNPs. It is expressed in a wide variety of tissues, including high levels in brain, kidney and liver, moderate levels in skeletal and cardiac muscle and low levels in fibroblasts and lymphocytes. Mutations in SMN cause spinal muscular atrophy 1 (SMA1). Spinal muscular atrophy is a group of neuromuscular disorders characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. The antibody was used extensively to purify and characterize the macromolecular SMN complex from cultured human cells. The antibody binds with high affinity and specificity to its epitope, which comprises a sequence of up to 9 amino acids in the N-terminal part of human SMN. It allows the native elution of bound antigen with an excess of the cognate peptide. Via addition of the 7B10 epitope (TagIt epitope) to other proteins this purification strategy can also be exploited for purification of these fusion proteins and RNA-protein complexes from cells lacking this epitope on endogenous proteins, such as cells derived from C. elegans and Drosophila.

    UniProt

    Q16637

    Pathways

    Ribonucleoprotein Complex Subunit Organization
You are here:
Chat with us!